Close Menu
  • Home
  • Europe
  • United Kingdom
  • World
  • Politics
  • Business
  • Culture
  • Health
  • Sports
  • Tech
  • Travel
Trending

Woman fractured skull before ex ‘strangled her to death in luxury Surrey hotel’

July 18, 2025

Essex students killed after drink-driver lost control doing 90mph in 30mph zone

July 18, 2025

Ex-Lioness Eni Aluko ‘did a lot to try and apologise’ to Ian Wright privately

July 18, 2025
Facebook X (Twitter) Instagram
Facebook X (Twitter) Instagram YouTube
Se Connecter
July 18, 2025
Euro News Source
Live Markets Newsletter
  • Home
  • Europe
  • United Kingdom
  • World
  • Politics
  • Business
  • Culture
  • Health
  • Sports
  • Tech
  • Travel
Euro News Source
Home»Health
Health

Experimental drug may slow dementia onset for patients with rare genetic form of Alzheimer’s

News RoomBy News RoomMarch 20, 2025
Facebook Twitter WhatsApp Copy Link Pinterest LinkedIn Tumblr Email Telegram

Introduction
The study highlights a novel experimental low-dose anti-amyloid treatment now being tested inPhase 3 trials to delay the onset of Alzheimer’s disease for asymptomatic patients. Primer, presented in clinical research, focuses on how this treatment could potentially bear the brunt of the disease burden.

Methodology and Results
The experiment involves 22 patients with genetic mutations that overproduce amyloid plaques in the brain, which contribute to the formation of Alzheimer’s plaques. During an 8-year treatment period, these patients showed a 50% reduction in the risk of committing Alzheimer’s disease compared to those who did not receive treatment ( baseline risk was 100%). As reported in the Lancet Neurology journal, the phase 3 trial was designed to be the first to demonstrate that early prevention could mitigate the risk of development.

The findings suggest that initial anti-amyloid therapy could delay the onset of Alzheimer’S symptoms, providing an opportunity for individuals to maintain cognitive function normally. Researchers have noted that these results align with earlier studies that link early anti-amyloid therapy to cognitive stability and reduced risk of progression.

Limitations of the Study
Despite these early results, the study has several limitations. First, it was based on a relatively small and homogeneous group of patients, which limits the generalizability of the findings. Second, the efficacy of gantenerumab, the drug tested, may not be as effective as other amyloid-reducing treatments currently available, as highlighted in a statement by Dr. Charles Marshall.

Despite these limitations, the potential benefits of early prevention are significant. The trial results indicate that anti-amyloid therapy could be a more effective approach to slowing the progression of Alzheimer’s disease, particularly in the early years of onset, and provide reassurance to patients and caregivers about the need for continued vicarious support.

Future Directions
Future research should address the other limitations of the study and explore the full range of amyloid-reducing therapies, including those that show greater efficacy for non-genetic stages of Alzheimer’s disease. Furthermore, the magnitude of the benefits of anti-amyloid therapy for prevention should be evaluated across a larger, diverse population, while also investigating potential side effects and mechanisms of action.

Summary
In summary, this phase 3 trial of anti-amyloid therapy is showing promising preliminary results in reducing the risk of Alzheimer’s disease in early-stage patients. While the study has limitations, particularly in adequately assessing large-scale populations and the lack of comprehensive validation for non-genetic amyloid stages, the findings suggest that early prevention could be a key component in reducing the burden of cognitive decline.

Share. Facebook Twitter Pinterest LinkedIn Telegram WhatsApp Email

Keep Reading

Brazilian movement practice helps Parkinson’s patients ease their symptoms and find support

Health July 16, 2025

Greece passes law to jail people for selling alcohol or tobacco to children

Health July 4, 2025

Global health officials urge countries to raise ‘sin taxes’ on tobacco, alcohol, and sugary drinks

Health July 4, 2025

Eating lots of red meat, other inflammatory foods during pregnancy raises risk of childhood diabetes

Health July 2, 2025

With new tobacco rules, Greece wants to stop parents from sending children to buy cigarettes

Health June 30, 2025

Greek health authorities issue alert after man dies of rare tick-borne illness

Health June 30, 2025

Heatwaves are coming to Europe. Here are 5 ways extreme heat can affect your health

Health June 30, 2025

Will we ever know for sure how COVID-19 began? Not without more data from China, WHO says

Health June 30, 2025

A child died in a food poisoning outbreak in France. How can you stay safe from E. coli?

Health June 27, 2025

Editors Picks

Essex students killed after drink-driver lost control doing 90mph in 30mph zone

July 18, 2025

Ex-Lioness Eni Aluko ‘did a lot to try and apologise’ to Ian Wright privately

July 18, 2025

Over a thousand flock to Swingathon as village hosts UK’s biggest taboo festival

July 18, 2025

At least three killed in explosion at Los Angeles training facility for sheriffs

July 18, 2025

Latest News

Belgium’s Tomorrowland festival opens after massive fire destroyed main stage

July 18, 2025

BREAKING: Epping protest: Cops break silence on claims police van drove into protester

July 18, 2025

Trinidad and Tobago imposes state of emergency after prison plot to kill officials uncovered

July 18, 2025

Subscribe to News

Get the latest Europe and World news and updates directly to your inbox.

Facebook X (Twitter) Pinterest Instagram
2025 © Euro News Source. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Sign In or Register

Welcome Back!

Login to your account below.

Lost password?